# ðŸ“š Master Bibliography: Project Acridine
**Project ID:** ACR-OPT-2026
**Date:** 2025-12-25
**Note:** This document compiles all citations for software, data, and methodologies used in this study.

---

## 1. Computational Software & Libraries
*These are the specific tools and versions used to generate the data.*

* **RDKit (Chemoinformatics):**
    * Landrum, G., et al. (2023). *RDKit: Open-source cheminformatics*. https://www.rdkit.org
* **scikit-learn (Machine Learning):**
    * Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., ... & Duchesnay, E. (2011). Scikit-learn: Machine Learning in Python. *Journal of Machine Learning Research*, 12, 2825-2830.
* **AutoDock Vina (Molecular Docking):**
    * Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. *Journal of Computational Chemistry*, 31(2), 455-461.
* **Meeko (Ligand Preparation):**
    * Forli Lab. (2023). *Meeko: Preparation of small molecules for AutoDock Vina*. https://github.com/forlilab/meeko
* **Matplotlib (Visualization):**
    * Hunter, J. D. (2007). Matplotlib: A 2D graphics environment. *Computing in Science & Engineering*, 9(3), 90-95.
* **PyMOL (Molecular Visualization):**
    * SchrÃ¶dinger, LLC. (2015). *The PyMOL Molecular Graphics System, Version 1.8*.

## 2. Biological Data Sources
*The specific protein structures retrieved from public databases.*

* **Human Topoisomerase II Beta (Target Receptor):**
    * Wu, C. C., Li, T. K., Farh, L., Lin, L. Y., Lin, T. S., Yu, Y. J., ... & Liu, L. F. (2011). Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. *Science*, 333(6041), 459-462. 
    * *PDB ID:* [3QX3](https://www.rcsb.org/structure/3QX3)

## 3. Theoretical Frameworks & Methods
*The scientific theories that guided the optimization strategy.*

* **Quantitative Estimate of Drug-likeness (QED):**
    * Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012). Quantifying the chemical beauty of drugs. *Nature Chemistry*, 4(2), 90-98.
* **Lipinski's Rule of Five:**
    * Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. *Advanced Drug Delivery Reviews*, 46(1-3), 3-26.
* **Random Forest Regression:**
    * Breiman, L. (2001). Random forests. *Machine Learning*, 45(1), 5-32.
* **Bioisosterism in Drug Design:**
    * Patani, G. A., & LaVoie, E. J. (1996). Bioisosterism: A rational approach in drug design. *Chemical Reviews*, 96(8), 3147-3176.

---

## 4. How to Cite This Work
*If you present this portfolio, use the following format:*

> [Your Name]. (2026). *Computational Optimization of Acridine Scaffolds for Enhanced Drug-Likeness and Topoisomerase II Inhibition*. Undergraduate Research Portfolio.
